Available online on 15.03.2026 at ijmspr.com

 International Journal of Medical Sciences and Pharma Research 

Open Access to Medical Science and Pharma Research

Copyright  © 2026 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

 

Bridging the Gaps: Public Health Strategies for Early Detection and Prevention of Breast Cancer

* Emmanuel Ifeanyi Obeagu ^1,2

¹ Division of Haematology, Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.

² The Division of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

 

 

Introduction

Breast cancer is the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. In 2020, over 2.3 million women were diagnosed with breast cancer, resulting in nearly 685,000 deaths. While advancements in diagnostic technologies, therapeutic modalities, and public awareness have improved outcomes in high-resource settings, significant disparities persist in low- and middle-income countries (LMICs), where late-stage diagnosis, limited access to screening, and inadequate healthcare infrastructure contribute to higher mortality rates ^1-2. Early detection and prevention are central to reducing the burden of breast cancer. Screening programs, including mammography, clinical breast examination (CBE), and ultrasonography, enable the identification of tumors at stages where treatment is more effective, improving survival and quality of life. Preventive interventions, such as lifestyle modification, risk reduction counseling, and vaccination programs, can mitigate the risk of disease onset and complement early detection efforts. However, gaps remain in awareness, accessibility, and follow-up care, particularly in underserved populations ^3-5.

Public health strategies provide a framework to address these gaps by combining education, screening, community engagement, and health system strengthening. Health education initiatives raise knowledge about risk factors, early warning signs, and the importance of regular screening, while culturally tailored approaches ensure that messages resonate with local populations. Community engagement empowers individuals and networks to participate actively in breast health promotion, facilitating adherence to preventive and screening behaviors. Meanwhile, policy advocacy and system-level interventions support equitable access, resource allocation, and program sustainability ^6-8. This narrative review explores evidence-based public health strategies for the early detection and prevention of breast cancer, highlighting successful models, persistent challenges, and opportunities for integration. By synthesizing global and local experiences, the review emphasizes comprehensive, context-specific approaches that bridge the gap between awareness and actionable interventions, ultimately improving breast cancer outcomes and reducing disparities across populations.

Awareness and Health Education

Awareness and health education form the foundation of public health strategies for breast cancer prevention and early detection. Effective programs aim to increase knowledge of risk factors, early warning signs, and the importance of timely screening while simultaneously addressing misconceptions, stigma, and cultural barriers that may prevent women from seeking care ^9-10. Health education initiatives can take many forms, including community workshops, school-based programs, media campaigns, and peer-led interventions. Culturally tailored messaging ensures that information resonates with local beliefs, literacy levels, and social norms, making it more likely to influence behavior. For example, programs that incorporate local language, visual aids, and storytelling have been shown to improve understanding and retention of breast health information ^11-12.

Digital health tools further expand the reach of education efforts. Social media campaigns, mobile phone messaging, and tele-education platforms enable dissemination of timely, targeted information to broad audiences, including younger women and individuals in remote areas. These tools also facilitate interactive engagement, allowing participants to ask questions, share experiences, and receive personalized guidance ^13-14. Sustained awareness initiatives must be closely linked to accessible services to translate knowledge into action. Encouraging breast self-examination or clinical visits is only effective if women have clear pathways to diagnostic and treatment services. Integration of health education with local healthcare facilities, screening programs, and community support systems ensures that awareness leads to tangible health-seeking behavior ^15-16.

Population-Based Screening Programs

Population-based screening is a cornerstone of early breast cancer detection, enabling diagnosis at stages when treatment is more effective and survival outcomes are improved. Screening strategies include mammography, clinical breast examination (CBE), and, in some contexts, ultrasonography, with selection tailored to resource availability, population risk profiles, and healthcare infrastructure ^17-18. Evidence demonstrates that organized mammography programs in high-resource settings can reduce breast cancer mortality by 20–30%, particularly among women aged 50–69 years. Such programs rely on systematic invitations, standardized screening intervals, quality control protocols, and coordinated follow-up to ensure that detected abnormalities are promptly addressed. These elements are essential for maximizing the benefits of early detection ^19-20.

In low- and middle-income countries (LMICs), where access to mammography may be limited, alternative approaches such as CBE conducted by trained healthcare workers offer a cost-effective strategy. Mobile screening units, community health campaigns, and integration of screening into primary healthcare services further expand coverage, particularly for rural or underserved populations. Data-driven planning, informed by public health surveillance, ensures that screening initiatives target high-risk groups and optimize resource allocation ^21-22. Screening programs are most effective when combined with public education, community engagement, and referral systems that facilitate timely diagnosis and treatment. By linking awareness campaigns with accessible screening services, health systems can transform knowledge into action, increasing participation, reducing delays in diagnosis, and ultimately improving survival 23-24.

Community Engagement and Participatory Approaches

Community engagement is a vital strategy for bridging the gap between awareness and actionable health behaviors in breast cancer prevention and early detection. Participatory approaches involve local populations in the planning, implementation, and evaluation of public health programs, ensuring interventions are culturally relevant, socially acceptable, and more likely to be effective ²⁵. Programs that leverage community health workers, peer educators, and local leaders have demonstrated improved participation in screening, adherence to follow-up care, and uptake of preventive behaviors. Faith-based organizations, women’s groups, and other community networks serve as trusted conduits for health messaging, reducing stigma and encouraging collective action. These strategies are particularly effective in underserved or rural areas where healthcare access is limited ²⁶.

Digital platforms, such as social media, mobile messaging, and tele-education, further facilitate community engagement by enabling interactive health promotion, peer-to-peer support, and real-time dissemination of breast health information. Such tools complement traditional outreach, reaching younger populations and geographically isolated communities ²⁷. Community engagement also fosters empowerment and self-efficacy, enabling individuals to make informed decisions regarding screening, lifestyle modification, and follow-up care. When communities participate actively in program design and implementation, interventions are more likely to be contextually appropriate, sustainable, and scalable ²⁸.

Risk Reduction and Preventive Interventions

Risk reduction and preventive strategies are essential components of comprehensive public health approaches to breast cancer. These interventions aim to decrease the likelihood of disease onset and complement early detection efforts, ultimately reducing morbidity and mortality. Lifestyle modification is a cornerstone of risk reduction. Evidence indicates that maintaining a healthy body weight, engaging in regular physical activity, adopting a balanced diet, limiting alcohol consumption, and avoiding tobacco use can significantly lower breast cancer risk. Public health programs that incorporate behavior change strategies—through education, community support, and environmental facilitation—encourage sustainable adoption of these healthy practices ²⁹. Targeted preventive interventions are particularly important for high-risk populations. Genetic counseling and risk assessment enable identification of individuals with hereditary predispositions, such as BRCA1/BRCA2 mutations. For these groups, strategies may include enhanced surveillance, chemoprevention, or prophylactic surgical interventions. Integrating risk stratification into public health programs ensures efficient resource allocation and maximizes impact ³⁰.

Vaccination programs, including human papillomavirus (HPV) vaccination, contribute indirectly to breast cancer prevention in populations where viral infections may be implicated in carcinogenesis. Public health initiatives that promote vaccination, along with education on infection prevention and reproductive health, reinforce a broader cancer prevention framework ³¹. Combining individual-level risk reduction with population-based strategies—such as mass education campaigns, community engagement, and screening programs—creates a comprehensive approach to prevention. Public health programs that integrate these components provide women with the knowledge, tools, and support needed to adopt preventive behaviors and access timely care ³².

Policy Advocacy and Health System Strengthening

Policy advocacy and health system strengthening are critical for ensuring that breast cancer early detection and prevention strategies are sustainable, equitable, and effective. Advocacy efforts aim to influence decision-makers to prioritize breast cancer control, allocate adequate resources, and implement policies that support access to screening, diagnostic, and treatment services. Effective advocacy involves collaboration among government agencies, non-governmental organizations, professional associations, and patient advocacy groups. Evidence generated from public health surveillance and program evaluation can be leveraged to highlight disparities, justify funding, and inform the development of national cancer control strategies. Policies may include legislation for universal screening coverage, funding for diagnostic infrastructure, guidelines for clinical management, and integration of breast health services into primary healthcare platforms ³⁴.

Strengthening health systems ensures that policy initiatives translate into actionable services. Key components include training healthcare personnel in early detection and oncology care, expanding diagnostic capacity (imaging and pathology services), establishing referral networks, and implementing patient navigation systems to reduce loss to follow-up. Robust health information systems facilitate data-driven decision-making, program monitoring, and evaluation, enhancing accountability and continuous improvement 35. Multisectoral collaboration amplifies these efforts. Partnerships with international organizations, academic institutions, and community-based organizations support capacity building, technical assistance, and resource mobilization, particularly in low- and middle-income countries. Such coordinated efforts ensure that policies are contextually appropriate, evidence-based, and scalable, addressing both structural and social determinants of breast cancer outcomes.

Conclusion

Bridging the gaps in breast cancer control requires comprehensive public health strategies that integrate awareness, early detection, preventive interventions, community engagement, and health system strengthening. Evidence demonstrates that culturally tailored, accessible, and coordinated programs improve screening uptake, promote preventive behaviors, and enhance survival outcomes. Effective public health strategies go beyond raising awareness—they link knowledge to actionable services, ensure equitable access, and provide structural support through policy and system-level interventions. Community participation, digital tools, and multisectoral collaboration further strengthen the impact and sustainability of programs.

Acknowledgements: Not applicable.

Conflict of Interest: The author declares that there no conflicts of interest.

Author Contributions: Emmanuel Ifeanyi Obeagu performed the following: Conceptualization, Methodology, Visualization, Validity, Supervision, Writing and Editing the Manuscript. 

Source of Support: Nil 

Funding: The author declared that this study has received no financial support. 

Informed Consent Statement: Not applicable.

Data Availability Statement: No data was generated in this narrative review article. 

Ethical approval: Not applicable.

References

1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022; 66:15-23. PMid:36084384 PMCid: PMC9465273  https://doi.org/10.1016/j.breast.2022.08.010 

2. Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183-1194. https://doi.org/10.1002/cac2.12207 nPMid:34399040 PMCid:PMC8626596

3. Obeagu EI. N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications. Breast cancer (Dove Medical Press), 2025; 17: 639-651.  PMid:40718361 PMCid:PMC12296999 https://doi.org/10.2147/BCTT.S542787 

4. Obeagu EI, Obeagu GU. Exploring the profound link: Breastfeeding's impact on alleviating the burden of breast cancer - A review. Medicine, 2024; 103(15), e37695. PMid:38608095 PMCid: PMC11018178  https://doi.org/10.1097/MD.0000000000037695 

5. Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18(9):986-993.  PMid:23939284 PMCid:PMC3780646 https://doi.org/10.1634/theoncologist.2013-0243 

6. Obeagu EI, Obeagu GU. Lymphocyte infiltration in breast cancer: A promising prognostic indicator. Medicine, 2024; 103(49), e40845. https://doi.org/10.1097/MD.0000000000040845 PMid:39654199 PMCid:PMC11631027

7. Obeagu EI, Obeagu GU. Exploring neutrophil functionality in breast cancer progression: A review. Medicine, 2024; 103(13), e37654. https://doi.org/10.1097/MD.0000000000037654 PMid:38552040 PMCid:PMC10977563

8. Bradley CJ, Kitchen S, Bhatia S, Bynum J, Darien G, Lichtenfeld JL, Oyer R, Shulman LN, Sheldon LK. Policies and Practices to Address Cancer's Long-Term Adverse Consequences. J Natl Cancer Inst. 2022;114(8):1065-https://doi.org/10.1093/jnci/djac086 PMid:35438165 PMCid:PMC93604639. Obeagu EI , Isiko I, N1 and N2 Neutrophils in Breast Cancer: Mechanisms, Clinical Relevance, and Therapeutic Potential, International Journal of Medical Sciences and Pharma Research. 2025;11(2):1-11 https://doi.org/10.22270/ijmspr.v11i2.141

10. Gbenonsi GY, Martini J, Mahieu C. An analytical framework for breast cancer public policies in Sub-Saharan Africa: results from a comprehensive literature review and an adapted policy Delphi. BMC Public Health. 2024;24(1):1535. PMid:38849808 PMCid:PMC11157826 https://doi.org/10.1186/s12889-024-18937-5 

11. Espina C, Soerjomataram I, Forman D, Martín-Moreno JM. Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind. J Cancer Policy. 2018; 18:40-51. https://doi.org/10.1016/j.jcpo.2018.09.001 PMid:30510896 PMCid:PMC6255794

12. Obeagu EI. The selenium paradox friend or foe in breast cancer? Ann Med Surg (Lond). 2025;87(9):5569-5577. https://doi.org/10.1097/MS9.0000000000003464 PMid:40901095 PMCid:PMC12401276

13. Obeagu EI , Isiko I, N1 and N2 Neutrophil Polarization in Breast Cancer: Predictive Value for Treatment Outcomes, International Journal of Medical Sciences and Pharma Research. 2025;11(2):12-20 https://doi.org/10.22270/ijmspr.v11i2.142

14. Shetty MK. Screening for breast cancer with mammography: current status and an overview. Indian J Surg Oncol. 2010;1(3):218-223. https://doi.org/10.1007/s13193-010-0014-x PMid:22693368 PMCid:PMC3244246

15. Ponce-Chazarri L, Ponce-Blandón JA, Immordino P, Giordano A, Morales F. Barriers to Breast Cancer-Screening Adherence in Vulnerable Populations. Cancers (Basel). 2023;15(3):604. https://doi.org/10.3390/cancers15030604 PMid:36765561 PMCid:PMC9913751

16. Obeagu EI. The nutritional equation: decoding diet's influence on breast cancer risk and progression - a perspective. Ann Med Surg (Lond). 2025;87(9):5528-5534. https://doi.org/10.1097/MS9.0000000000003612 PMid:40901208 PMCid:PMC12401440

17. Gbenonsi GY, Martini J, Mahieu C. An analytical framework for breast cancer public policies in Sub-Saharan Africa: results from a comprehensive literature review and an adapted policy Delphi. BMC Public Health. 2024;24(1):1535. PMid:38849808 PMCid: PMC11157826 https://doi.org/10.1186/s12889-024-18937-5 

18. Obeagu EI, Maibouge Tanko MS. Iron metabolism in breast cancer: mechanisms and therapeutic implications: a narrative review. Ann Med Surg (Lond). 2025;87(6):3403-3409. https://doi.org/10.1097/MS9.0000000000003173 PMid:40486542 PMCid:PMC12140789

19. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033. https://doi.org/10.1259/bjr.20211033 PMid:34905391 PMCid:PMC8822551

20. Obeagu EI. Thromboinflammatory pathways in breast cancer: clinical and molecular insights into venous thromboembolism risk - a narrative review. Ann Med Surg (Lond). 2025;87(9):5822-5828. https://doi.org/10.1097/MS9.0000000000003644 PMid:40901130 PMCid:PMC12401306

21. Kitaw TA, Tilahun BD, Zemariam AB, Getie A, Bizuayehu MA, Haile RN. The financial toxicity of cancer: unveiling global burden and risk factors - a systematic review and meta-analysis. BMJ Glob Health. 2025;10(2): e017133. https://doi.org/10.1136/bmjgh-2024-017133 PMid:39929536 PMCid:PMC11815433

22. Obeagu EI, Obeagu GU. Predictive models and biomarkers for survival in stage III breast cancer: a review of clinical applications and future directions. Ann Med Surg (Lond). 2024;86(10):5980-5987. https://doi.org/10.1097/MS9.0000000000002517 PMid:39359789 PMCid:PMC11444610

23. Bhatia S, Landier W, Paskett ED, Peters KB, Merrill JK, Phillips J, Osarogiagbon RU. Rural-Urban Disparities in Cancer Outcomes: Opportunities for Future Research. J Natl Cancer Inst. 2022;114(7):940-952. https://doi.org/10.1093/jnci/djac030 PMid:35148389 PMCid:PMC9275775

24. Malope SD, Norris SA, Joffe M. Culture, community, and cancer: understandings of breast cancer from a non-lived experience among women living in Soweto. BMC women's health, 2024; 24(1), 594. https://doi.org/10.1186/s12905-024-03431-2 PMid:39506786 PMCid:PMC11539428

25. Sítima G, Galhardo-Branco C, Reis-Pina P. Equity of access to palliative care: a scoping review. Int J Equity Health. 2024;23(1):248. https://doi.org/10.1186/s12939-024-02321-1 PMid:39581966 PMCid:PMC11587758

26. Kreuter MW, Thompson T, McQueen A, Garg R. Addressing Social Needs in Health Care Settings: Evidence, Challenges, and Opportunities for Public Health. Annu Rev Public Health. 2021; 42:329-344. https://doi.org/10.1146/annurev-publhealth-090419-102204 PMid:33326298 PMCid:PMC8240195

27. Aslam A, Mustafa AG, Hussnain A, Saeed H, Nazar F, Amjad M, Mahmood A, Afzal A, Fatima A, Alkhalidi DK. Assessing Awareness, Attitude, and Practices of Breast Cancer Screening and Prevention Among General Public and Physicians in Pakistan: A Nation with the Highest Breast Cancer Incidence in Asia. Int J Breast Cancer. 2024; 2024:2128388. https://doi.org/10.1155/2024/2128388 PMid:39372363 PMCid:PMC11455591

28. Alrosan AZ, Alwidyan T, Heilat GB, Rataan AO, Madae'en S, Alrosan K, Awwad FS, Ali T. Knowledge and awareness of breast cancer signs and symptoms among Jordanian women. Future Sci OA. 2025;11(1):2510871. PMid:40435211 PMCid:PMC12123941 https://doi.org/10.1080/20565623.2025.2510871 

29. Turkson-Ocran RN, Nkimbeng M, Erol D, Hwang DA, Aryitey AA, Hughes V. Strategies for Providing Culturally Sensitive Care to Diverse Populations. J Christ Nurs. 2022 Jan;39(1):16-21. https://doi.org/10.1097/CNJ.0000000000000900 PMid:34860764 PMCid:PMC9976714

30. Wakefield, MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376(9748):1261-1271. https://doi.org/10.1016/S0140-6736(10)60809-4 PMid:20933263 PMCid:PMC4248563

31. AlMutawah K, Taqi G, Radhwan S, AlMutairi A, AlHussainan A, Faraj M, AlBaloul AH. Knowledge and awareness of breast cancer symptoms, risk factors, and screening barriers among women in Kuwait: a cross-sectional study. BMC Womens Health. 2025;25(1):448. https://doi.org/10.1186/s12905-025-03994-8 PMid:41013463 PMCid:PMC12465561

32. Gbenonsi GY, Martini J, Mahieu C. An analytical framework for breast cancer public policies in Sub-Saharan Africa: results from a comprehensive literature review and an adapted policy Delphi. BMC Public Health. 2024;24(1):1535. https://doi.org/10.1186/s12889-024-18937-5 PMid:38849808 PMCid:PMC11157826

33. Al Hasan SM, Bennett DL, Toriola AT. Screening programmes and breast cancer mortality: an observational study of 194 countries. Bull World Health Organ. 2025;103(8):470-483. https://doi.org/10.2471/BLT.24.292529 PMid:40766731 PMCid:PMC12322760

34. Iqbal J. Women-Centric Breast Cancer Care in Low- and Middle-Income Countries: Challenges, Solutions, and a Roadmap for Equity. Cancer Control. 2025 Jan-Dec; 32:10732748251378804. https://doi.org/10.1177/10732748251378804 PMid:40956982 PMCid:PMC12441264

35. Caldwell HAT, Yusuf J, Carrea C, Conrad P, Embrett M, Fierlbeck K, Hajizadeh M, Kirk SFL, Rothfus M, Sampalli T, Sim SM, Tomblin Murphy G, Williams L. Strategies and indicators to integrate health equity in health service and delivery systems in high-income countries: a scoping review. JBI Evid Synth. 2024;22(6):949-1070. https://doi.org/10.11124/JBIES-23-00051 PMid:38632975 PMCid:PMC11163892